J Laudański

1.2k total citations
54 papers, 966 citations indexed

About

J Laudański is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J Laudański has authored 54 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Surgery and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J Laudański's work include Esophageal Cancer Research and Treatment (16 papers), Cancer-related Molecular Pathways (11 papers) and Peptidase Inhibition and Analysis (10 papers). J Laudański is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Cancer-related Molecular Pathways (11 papers) and Peptidase Inhibition and Analysis (10 papers). J Laudański collaborates with scholars based in Poland, United States and Germany. J Laudański's co-authors include Jacek Nikliński, L Chyczewski, Mirosław Kozłowski, Wiesława Niklińska, M Furman, E Chyczewska, Maciej Szmitkowski, Barbara Mroczko, Tomasz Burzykowski and Marta Łukaszewicz‐Zając and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and British Journal of Pharmacology.

In The Last Decade

J Laudański

54 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Laudański Poland 19 436 360 314 221 181 54 966
Philippe Lothaire Belgium 12 528 1.2× 410 1.1× 691 2.2× 118 0.5× 198 1.1× 36 1.2k
Fang‐Yun Xie China 18 415 1.0× 328 0.9× 265 0.8× 383 1.7× 181 1.0× 69 1.2k
Georgia Sotiropoulou‐Bonikou Greece 16 252 0.6× 445 1.2× 109 0.3× 126 0.6× 210 1.2× 36 973
Kyoichi Ogata Japan 20 252 0.6× 365 1.0× 405 1.3× 245 1.1× 99 0.5× 60 1.0k
Joseph M. Giaconia United States 11 262 0.6× 801 2.2× 629 2.0× 264 1.2× 242 1.3× 14 1.6k
Sun Il Lee South Korea 18 631 1.4× 308 0.9× 181 0.6× 466 2.1× 133 0.7× 47 1.2k
Shan Yu China 17 309 0.7× 483 1.3× 250 0.8× 104 0.5× 298 1.6× 61 1.0k
Robert X.-D. Song United States 17 574 1.3× 807 2.2× 95 0.3× 225 1.0× 206 1.1× 19 1.8k
Cheng Xu China 17 229 0.5× 439 1.2× 191 0.6× 144 0.7× 344 1.9× 99 1.1k
Zhikang Chen China 19 245 0.6× 690 1.9× 129 0.4× 102 0.5× 378 2.1× 64 1.1k

Countries citing papers authored by J Laudański

Since Specialization
Citations

This map shows the geographic impact of J Laudański's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Laudański with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Laudański more than expected).

Fields of papers citing papers by J Laudański

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Laudański. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Laudański. The network helps show where J Laudański may publish in the future.

Co-authorship network of co-authors of J Laudański

This figure shows the co-authorship network connecting the top 25 collaborators of J Laudański. A scholar is included among the top collaborators of J Laudański based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Laudański. J Laudański is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chyczewski, L, J Laudański, Jacek Nikliński, et al.. (2009). Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer.. SHILAP Revista de lepidopterología. 3 indexed citations
4.
Jelski, Wojciech, Mirosław Kozłowski, J Laudański, Jacek Nikliński, & Maciej Szmitkowski. (2009). Alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the sera of patients with esophageal cancer. Clinical and Experimental Medicine. 9(2). 131–137. 13 indexed citations
5.
Mróz, Robert, Mirosław Kozłowski, Andrzej Baniukiewicz, et al.. (2008). Severe respiratory distress caused by central airway obstruction treated with self-expandable metallic stents.. PubMed. 59 Suppl 6. 491–7. 29 indexed citations
6.
Sulewska, Anetta, Wiesława Niklińska, Wojciech Naumnik, et al.. (2008). Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer.. Folia Histochemica et Cytobiologica. 46(1). 89–96. 3 indexed citations
7.
Jelski, Wojciech, Mirosław Kozłowski, J Laudański, Jacek Nikliński, & Maciej Szmitkowski. (2008). The Activity of Class I, II, III, and IV Alcohol Dehydrogenase (ADH) Isoenzymes and Aldehyde Dehydrogenase (ALDH) in Esophageal Cancer. Digestive Diseases and Sciences. 54(4). 725–730. 23 indexed citations
8.
Mroczko, Barbara, Mirosław Kozłowski, Magdalena Groblewska, et al.. (2007). The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. Clinica Chimica Acta. 389(1-2). 61–66. 75 indexed citations
9.
Kozłowska, Hanna, et al.. (2007). Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery. Journal of Hypertension. 25(11). 2240–2248. 45 indexed citations
10.
Kozłowski, Mirosław, Oksana Kowalczuk, Anetta Sulewska, et al.. (2007). Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.. SHILAP Revista de lepidopterología. 45(3). 199–204. 19 indexed citations
11.
Nikliński, Jacek, Wiesława Niklińska, E Chyczewska, et al.. (2004). The epidemiology of asbestos-related diseases. Lung Cancer. 45. S7–S15. 42 indexed citations
12.
Niklińska, Wiesława, L Chyczewski, J Laudański, E Chyczewska, & Jacek Nikliński. (2001). Detection of p16 abnormalities in early-stage non-small cell lung cancer.. PubMed. 39 Suppl 2. 30–2. 6 indexed citations
13.
Nikliński, Jacek, Wiesława Niklińska, J Laudański, E Chyczewska, & L Chyczewski. (2001). Prognostic molecular markers in non-small cell lung cancer. Lung Cancer. 34. S53–S58. 81 indexed citations
14.
Laudański, J, Mirosław Kozłowski, Jacek Nikliński, & L Chyczewski. (2001). The preoperative study of mediastinal lymph nodes metastasis in lung cancer by endoscopic ultrasonography (EUS) and helical computed tomography (CT). Lung Cancer. 34. S123–S126. 15 indexed citations
15.
Laudański, J, Tomasz Burzykowski, Wiesława Niklińska, et al.. (1998). Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer. Lung Cancer. 22(3). 191–200. 24 indexed citations
16.
Nikliński, Jacek, Tomasz Burzykowski, Wiesława Niklińska, et al.. (1998). Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer. European Respiratory Journal. 12(6). 1424–1428. 27 indexed citations
17.
Nikliński, Jacek, M Furman, Tomasz Burzykowski, et al.. (1996). Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer. British Journal of Cancer. 74(6). 956–960. 19 indexed citations
18.
Nikliński, Jacek, M Furman, E Chyczewska, et al.. (1995). Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer. European Respiratory Journal. 8(2). 291–294. 45 indexed citations
19.
Nikliński, Jacek, M Furman, E Chyczewska, et al.. (1994). Evaluation of CYFRA 21–1 as a new marker for non-small cell lung cancer. European Journal of Cancer Prevention. 3(2). 227–230. 20 indexed citations
20.
Nikliński, Jacek, M Furman, J Laudański, & Mirosław Kozłowski. (1992). Prognostic value of pretreatment CEA, SCC-Ag and CA 19–9 levels in sera of patients with non-small cell lung cancer. European Journal of Cancer Prevention. 1(6). 401–406. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Lothaire Breakdown of academic impact, for papers by Fang‐Yun Xie Breakdown of academic impact, for papers by Georgia Sotiropoulou‐Bonikou Breakdown of academic impact, for papers by Kyoichi Ogata Breakdown of academic impact, for papers by Joseph M. Giaconia Breakdown of academic impact, for papers by Sun Il Lee Breakdown of academic impact, for papers by Shan Yu Breakdown of academic impact, for papers by Robert X.-D. Song Breakdown of academic impact, for papers by Cheng Xu Breakdown of academic impact, for papers by Zhikang Chen
Rankless by CCL
2026